These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 24417680)
1. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations. Trnka H; Rantanen J; Grohganz H Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680 [TBL] [Abstract][Full Text] [Related]
2. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System. Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647 [TBL] [Abstract][Full Text] [Related]
3. Near-infrared imaging for high-throughput screening of moisture induced changes in freeze-dried formulations. Trnka H; Palou A; Panouillot PE; Kauppinen A; Toiviainen M; Grohganz H; Alcalà M; Juuti M; Ketolainen J; Rantanen J J Pharm Sci; 2014 Sep; 103(9):2839-2846. PubMed ID: 24665039 [TBL] [Abstract][Full Text] [Related]
4. Impact of fast and conservative freeze-drying on product quality of protein-mannitol-sucrose-glycerol lyophilizates. Horn J; Schanda J; Friess W Eur J Pharm Biopharm; 2018 Jun; 127():342-354. PubMed ID: 29522899 [TBL] [Abstract][Full Text] [Related]
6. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol. Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270 [TBL] [Abstract][Full Text] [Related]
7. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process. Grohganz H; Lee YY; Rantanen J; Yang M Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620 [TBL] [Abstract][Full Text] [Related]
8. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage. Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475 [TBL] [Abstract][Full Text] [Related]
9. Screening of novel excipients for freeze-dried protein formulations. Holm TP; Meng-Lund H; Rantanen J; Jorgensen L; Grohganz H Eur J Pharm Biopharm; 2021 Mar; 160():55-64. PubMed ID: 33508435 [TBL] [Abstract][Full Text] [Related]
10. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying. Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123 [TBL] [Abstract][Full Text] [Related]
11. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying. Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G J Pharm Sci; 2010 May; 99(5):2256-78. PubMed ID: 20039389 [TBL] [Abstract][Full Text] [Related]
12. Formulations of sugars with amino acids or mannitol--influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate. Lueckel B; Bodmer D; Helk B; Leuenberger H Pharm Dev Technol; 1998 Aug; 3(3):325-36. PubMed ID: 9742553 [TBL] [Abstract][Full Text] [Related]
13. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying. Al-Hussein A; Gieseler H J Pharm Sci; 2012 Jul; 101(7):2534-44. PubMed ID: 22535541 [TBL] [Abstract][Full Text] [Related]
14. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations. Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444 [TBL] [Abstract][Full Text] [Related]
15. Fuzzy Logic-based expert system for evaluating cake quality of freeze-dried formulations. Trnka H; Wu JX; Van De Weert M; Grohganz H; Rantanen J J Pharm Sci; 2013 Dec; 102(12):4364-74. PubMed ID: 24258283 [TBL] [Abstract][Full Text] [Related]
16. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulation and process variables on residual solvents. Wittaya-Areekul S; Nail SL J Pharm Sci; 1998 Apr; 87(4):491-5. PubMed ID: 9548903 [TBL] [Abstract][Full Text] [Related]
18. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers. De Beer TR; Wiggenhorn M; Hawe A; Kasper JC; Almeida A; Quinten T; Friess W; Winter G; Vervaet C; Remon JP Talanta; 2011 Feb; 83(5):1623-33. PubMed ID: 21238761 [TBL] [Abstract][Full Text] [Related]
19. Use of subambient differential scanning calorimetry to monitor the frozen-state behavior of blends of excipients for freeze-drying. Martini A; Kume S; Crivellente M; Artico R PDA J Pharm Sci Technol; 1997; 51(2):62-7. PubMed ID: 9146035 [TBL] [Abstract][Full Text] [Related]
20. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design. Beirowski J; Inghelbrecht S; Arien A; Gieseler H J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]